Scott Hecker
78Patents
15h-index
80Co-inventors
87Inventor score
Filing activity: Jan 11, 1995 → Feb 21, 2024
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US8680136B2 | Cyclic boronic acid ester derivatives and therapeutic uses thereof | Emerging Cross-Sectional Technologies | 57 | Active |
| US9101638B2 | Boronic acid derivatives and therapeutic uses thereof | Emerging Cross-Sectional Technologies | 49 | Active |
| US5989832A | Method for screening for non-tetracycline efflux pump inhibitors | Emerging Cross-Sectional Technologies | 42 | Expired |
| US6020121A | Inhibitors of regulatory pathways | Human Necessities | 34 | Expired |
| US9132140B2 | Boronic acid derivatives and therapeutic uses thereof | Emerging Cross-Sectional Technologies | 30 | Active |
| US5883074A | Potentiators of antibacterial agents | Chemistry; Metallurgy | 28 | Expired |
| US9012491B2 | Heterocyclic boronic acid ester derivatives and therapeutic uses thereof | Emerging Cross-Sectional Technologies | 24 | Active |
| US9642869B2 | Boronic acid derivatives and therapeutic uses thereof | Emerging Cross-Sectional Technologies | 24 | Active |
| US9296763B2 | Cyclic boronic acid ester derivatives and therapeutic uses thereof | Emerging Cross-Sectional Technologies | 23 | Active |
| US9156858B2 | Boronic acid derivatives and therapeutic uses thereof | Emerging Cross-Sectional Technologies | 22 | Active |
| US6043238A | 2-Aminobenzazapine derivatives | Chemistry; Metallurgy | 20 | Expired |
| US7041670B2 | Florfenicol-type antibiotics | Emerging Cross-Sectional Technologies | 20 | Expired |
| US5545624A | Derivatives of 16-membered ring antibiotic macrolides | Human Necessities | 19 | Expired |
| US9694025B2 | Cyclic boronic acid ester derivatives and therapeutic uses thereof | Emerging Cross-Sectional Technologies | 18 | Active |
| US9241947B2 | Boronic acid derivatives and therapeutic uses thereof | Emerging Cross-Sectional Technologies | 16 | Active |
| US10004758B2 | Cyclic boronic acid ester derivatives and methods of making the same | Emerging Cross-Sectional Technologies | 15 | Active |
| US5789584A | Substituted-pyridinyl cephalosporin antibiotics active against methicillin resistant bacteria | Chemistry; Metallurgy | 15 | Expired |
| US9963467B2 | Boronic acid derivatives and therapeutic uses thereof | Emerging Cross-Sectional Technologies | 13 | Active |
| US10206937B2 | Boronic acid derivatives and therapeutic uses thereof | Emerging Cross-Sectional Technologies | 11 | Active |
| US8710236B2 | Antagonists of the glucagon receptor | Chemistry; Metallurgy | 9 | Active |
| US8907103B2 | Glucagon antagonists | Chemistry; Metallurgy | 8 | Active |
| US7153842B2 | Florfenicol prodrug having improved water solubility | Chemistry; Metallurgy | 8 | Expired |
| US8063025B2 | Nucleoside prodrugs and uses thereof | Chemistry; Metallurgy | 7 | Active |
| US6087355A | Cephalosporin antibiotics | Human Necessities | 7 | Expired |
| US9169201B2 | Antagonists of the glucagon receptor | Chemistry; Metallurgy | 7 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.